1. Home
  2. ABEV vs ALC Comparison

ABEV vs ALC Comparison

Compare ABEV & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambev S.A.

ABEV

Ambev S.A.

HOLD

Current Price

$2.79

Market Cap

40.4B

ML Signal

HOLD

Logo Alcon Inc.

ALC

Alcon Inc.

HOLD

Current Price

$80.35

Market Cap

39.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABEV
ALC
Founded
1885
1945
Country
Brazil
Switzerland
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Ophthalmic Goods
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.4B
39.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ABEV
ALC
Price
$2.79
$80.35
Analyst Decision
Hold
Buy
Analyst Count
4
12
Target Price
$2.53
$88.29
AVG Volume (30 Days)
22.8M
1.3M
Earning Date
02-12-2026
02-24-2026
Dividend Yield
6.90%
0.27%
EPS Growth
15.78
N/A
EPS
0.19
2.10
Revenue
$16,975,691,794.00
$10,185,000,000.00
Revenue This Year
$3.57
$5.76
Revenue Next Year
$4.38
$7.24
P/E Ratio
$14.59
$37.60
Revenue Growth
9.79
4.34
52 Week Low
$1.79
$71.55
52 Week High
$2.81
$99.20

Technical Indicators

Market Signals
Indicator
ABEV
ALC
Relative Strength Index (RSI) 75.16 52.40
Support Level $2.56 $78.27
Resistance Level $2.61 $82.14
Average True Range (ATR) 0.05 1.55
MACD 0.03 -0.02
Stochastic Oscillator 95.83 53.63

Price Performance

Historical Comparison
ABEV
ALC

About ABEV Ambev S.A.

Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: